Ton N.M. Schumacher
Affiliations: | 1996- | Netherlands Cancer Institute |
Website:
https://scienceforlife.sites.uu.nl/keynote-speakers/ton-schumacher/Google:
"Ton Schumacher"Bio:
Parents
Sign in to add mentor| Hidde L. Ploegh | grad student | 1992 | VU Amsterdam (Chemistry Tree) | |
| (Interactions of MHC class I molecules with antigenic peptides) | ||||
| Peter S. Kim | post-doc | 1994-1996 | Whitehead Institute for Biomedical Research (Chemistry Tree) | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Hoekstra ME, Slagter M, Urbanus J, et al. (2024) Distinct spatiotemporal dynamics of CD8 T cell-derived cytokines in the tumor microenvironment. Cancer Cell. 42: 157-167.e9 |
| Kenski JCN, Huang X, Vredevoogd DW, et al. (2023) An adverse tumor-protective effect of IDO1 inhibition. Cell Reports. Medicine. 4: 100941 |
| de Vries NL, van de Haar J, Veninga V, et al. (2023) γδ T cells are effectors of immunotherapy in cancers with HLA class I defects. Nature. 613: 743-750 |
| Cattaneo CM, Battaglia T, Urbanus J, et al. (2023) Identification of patient-specific CD4 and CD8 T cell neoantigens through HLA-unbiased genetic screens. Nature Biotechnology |
| Santegoets SJ, Welters MJP, Schrikkema DS, et al. (2022) The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer. Cancer Immunology, Immunotherapy : Cii |
| Haanen JB, Schumacher TN. (2022) Next generation T cell therapies for solid cancers. Med (New York, N.Y.). 3: 645-647 |
| Bresser K, Kok L, Swain AC, et al. (2022) Author Correction: Replicative history marks transcriptional and functional disparity in the CD8 T cell memory pool. Nature Immunology |
| Bresser K, Kok L, Swain AC, et al. (2022) Replicative history marks transcriptional and functional disparity in the CD8 T cell memory pool. Nature Immunology |
| van der Leun AM, Schumacher TN. (2021) An atlas of intratumoral T cells. Science (New York, N.Y.). 374: 1446-1447 |
| Ali M, Giannakopoulou E, Li Y, et al. (2021) T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes. Nature Biotechnology |